|65.00||+2.57 / +4.12%|
Data as of 4:00pm ET
|64.26||-0.74 / -1.14%|
The 18 analysts offering 12-month price forecasts for BioMarin Pharmaceutical Inc have a median target of 70.00, with a high estimate of 80.00 and a low estimate of 62.00. The median estimate represents a +7.69% increase from the last price of 65.00.
The current consensus among 23 polled investment analysts is to Buy stock in BioMarin Pharmaceutical Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.